HOME >> MEDICINE >> NEWS
Study shows patch therapy may be as effective as oral medications

Altoona, Pa., March 31, 2005 Researchers from the Altoona Arthritis and Osteoporosis Center announced today that data presented at the 24th Annual Scientific Meeting of the American Pain Society suggest that patch therapy provides similar pain relief as oral medications for patients with osteoarthritis (OA) knee pain. The exploratory study involved a head to head comparison of applying the lidocaine patch 5% (Lidoderm) or taking celecoxib (Celebrex) 200 mg per day.

In this study, results showed that at six weeks 54 % of patients treated in the lidocaine patch 5% (Lidoderm) group (N=56) and 62 % of patients in the celecoxib (Celebrex) group (N=63) experienced a 30 % or greater improvement in pain intensity. A 30 % or greater reduction in pain intensity is considered clinically meaningful to pain patients.

"These findings are encouraging for OA knee pain patients wanting alternatives to current oral medications," said Dr. Alan J. Kivitz, founder and lead physician, Altoona Arthritis and Osteoporosis Center, and study author. "With medication safety being on the minds of many people, it's promising for patients and their physicians that there are non-systemic therapies being studied for OA pain which may provide future options."

OA affects more than 20 million Americans annually and generates more than seven million physician visits per year. If left untreated, chronic pain conditions such as OA can have significant physical, psychological and financial consequences by impacting daily functioning and quality of life.

Analyzing results from 143 patients experiencing OA pain of either one or both knees, the randomized, open-label, active-control, parallel-group study found that clinically meaningful reductions in pain were noted in the lidocaine patch 5% and the celecoxib groups at week 12. In this study, 71 percent of patients in the lidocaine patch 5% group (N=24) and 72 percent of patients in the celecoxib group (N=39) experi
'"/>

Contact: Darren Roberts
darren_roberts@nyc.cohnwolfe.com
212-798-9778
Cohn & Wolfe
31-Mar-2005


Page: 1 2

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows soy is well accepted in school lunches
4. Study finds that coordinating care of chronically ill patients does not increase liability
5. Study provides new estimates of the causes of child mortality worldwide
6. Study finds factors linked to substance use disorder relapse among health care professionals
7. Study finds majority of women willing to accept cervical cancer vaccine for self and children
8. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
9. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
10. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women
11. Study of obese diabetics explains why low-carb diets produce fast results

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Study shows patch therapy may effective oral medications

(Date:5/22/2013)... US (PRWEB) May 22, 2013 Award ... , Read the press release here: http://bit.ly/13DkFfk ... DataSite® was named “Information Management Product/Service of the Year” ... in March at The Colony Hotel in Palm Beach, ... virtual data room (VDR) solution that optimizes ...
(Date:5/22/2013)... Utah (PRWEB) May 22, 2013 Registered Dietitian ... an article today on Tatalou.com sharing a recipe for making ... Your Own Healthy Energy Bars ,” takes a recipe modified ... few important twists. , “Every day it gets more and ... our bodies,” said Chevreau. “The size of the nutrition label ...
(Date:5/22/2013)... Pamela Isom, President and CEO of ICE Safety ... Women of Influence Award in recognition for her outstanding ... took place on Thursday, May 2 at The Fairmont, ... humbling for the 5,000 people ICE Safety Solutions certifies ... recognize the four to nine lives saved per year ...
(Date:5/22/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) ... children who die each year awaiting an organ donation ... increasing numbers of children are receiving donor organs. ... donors expanded to include not just patients who,ve experienced ... of death." But it,s unclear how much that ...
(Date:5/22/2013)... URBANA - A University of Illinois researcher says that ... should be to encourage more people to participate in ... , According to Craig Gundersen, SNAP, formerly known as ... net program and with some additional improvements could be ... households. Gundersen is a U of I professor of ...
Breaking Medicine News(10 mins):Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3Health News:How To "Make Your Own Healthy Energy Bars" 2Health News:Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 3Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 4Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 2Health News:Alleviating hunger in the US -- researcher says, it's a SNAP 3
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... is investigating potential claims on behalf of purchasers ... or the "Company") (NasdaqGS: AMAG -News).  The investigation ... violated federal securities laws. On May ... 10.73% during intraday trading after the company announced ...
(Date:5/22/2013)... , May 22, 2013  The Leukemia & ... million to Valor Biotherapeutics, LLC, a joint venture between ... development, manufacturing, and a Phase I clinical trial for ... outcomes faced by many patients with indolent lymphomas who ... Valor,s protein, IGN002, is a new class ...
(Date:5/22/2013)... May 22, 2013  The Lupus Research Institute (LRI) ... advancing new treatments for lupus nephritis, a serious kidney ... patients. The conference launched a new international alliance of ... Trials Network (LNTN). More than 50 of ... came together to focus on two critical questions: 1) ...
Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis 2
Cached News: